Cargando…

LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients

BACKGROUND: Lysosome-associated transmembrane protein 4β-35 (LAPTM4B-35), a member of the mammalian 4-tetratransmembrane spanning protein superfamily, has been reported to be overexpressed in several cancers. However the expression of LAPTM4B-35 and its role in the progression of gastric cancer (GC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Xiaojing, Zheng, Zhixue, Bu, Zhaode, Wu, Xiaojiang, Zhang, Lianhai, Xing, Xiaofang, Wang, Xiaohong, Hu, Ying, Du, Hong, Li, Lin, Li, Shen, Zhou, Rouli, Wen, Xian-Zi, Ji, Jia-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388692/ https://www.ncbi.nlm.nih.gov/pubmed/25849595 http://dx.doi.org/10.1371/journal.pone.0121559

Ejemplares similares

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer
por: Kong, Fanming, et al.
Publicado: (2016)

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis
por: Li, Maojin, et al.
Publicado: (2016)

A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients
por: Zheng, Zhixue, et al.
Publicado: (2016)

Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers
por: Cheng, Xiaojing, et al.
Publicado: (2016)

Relationship Between LAPTM4B Gene Polymorphism and Susceptibility of Malignant Melanoma in Chinese Patients
por: Zhang, Meng, et al.
Publicado: (2014)

LAPTM4B*2 allele is associated with the development of papillary thyroid carcinoma in Chinese women
por: Meng, Yue, et al.
Publicado: (2017)

Up-Regulation of SALL4 Is Associated With Survival and Progression via Putative WNT Pathway in Gastric Cancer
por: Yang, Yang, et al.
Publicado: (2021)

Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis
por: Zhou, Linghui, et al.
Publicado: (2018)

Impact of postoperative major complications on long-term survival after radical resection of gastric cancer
por: Yuan, Peng, et al.
Publicado: (2019)

Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis
por: Li, Ziyu, et al.
Publicado: (2019)

Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
por: Li, Sha, et al.
Publicado: (2017)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma
por: Zhai, Guojun, et al.
Publicado: (2012)

LAPTM4B Allele *2 Is Associated with Breast Cancer Susceptibility and Prognosis
por: Li, Xiaoyan, et al.
Publicado: (2012)

LAPTM4B-35 protein is a weak tumor-associated antigen candidate
por: SHI, GUILAN, et al.
Publicado: (2014)

LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells
por: Maki, Yuho, et al.
Publicado: (2015)

Down-regulation of LAPTM5 in human cancer cells
por: Nuylan, Michelle, et al.
Publicado: (2016)

LAPTM4B promotes the progression of nasopharyngeal cancer
por: Su, Qun, et al.
Publicado: (2021)

Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study
por: Li, Ziyu, et al.
Publicado: (2015)

Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial
por: Xue, Kan, et al.
Publicado: (2018)

Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2013)

Depth of tumor invasion and tumor-occupied portions of stomach are predictive factors of intra-abdominal metastasis
por: Li, Ziyu, et al.
Publicado: (2017)

Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
por: Pak, Youngshil, et al.
Publicado: (2006)

Correction: Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2014)

LAPTM4B‐35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics
por: Liu, Minxia, et al.
Publicado: (2022)

Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer
por: Zhang, Meng, et al.
Publicado: (2023)

Proposal for a New TNM Stage based on the 7(th) and 8(th) American Joint Committee on Cancer pTNM Staging Classification for Gastric Cancer
por: Qiu, Miao-Zhen, et al.
Publicado: (2018)

Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2019)

LAPTM4B-35 expression is associated with pathological grades and clinical stages in salivary adenoid cystic carcinoma
por: Fan, Jianlin, et al.
Publicado: (2020)

LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma
por: Yang, Hua, et al.
Publicado: (2012)

The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis
por: Xia, Ling-Zi, et al.
Publicado: (2015)

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
por: Li, Yang, et al.
Publicado: (2010)

Molecular characteristics of synchronous multiple gastric cancer
por: Wang, Anqiang, et al.
Publicado: (2020)

Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma
por: Ding, Huirong, et al.
Publicado: (2018)

CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients
por: Cao, Yifan, et al.
Publicado: (2016)

ARHGAP11A Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Fan, Biao, et al.
Publicado: (2021)

The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice
por: Zhang, Lianhai, et al.
Publicado: (2015)

The Glasgow Microenvironment Score and risk and site of recurrence in TNM I–III colorectal cancer
por: Alexander, P. G., et al.
Publicado: (2022)

Comparison of the 7th and 8th editions of the American joint committee on cancer TNM classification for patients with stage III gastric cancer
por: Lu, Jun, et al.
Publicado: (2017)

Relative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer
por: Reid, T D, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dqs6tcru9caujhij9k8gdthuie